Scholarlink

<p>Extrachromosomal DNA (ecDNA), autonomously replicating circular DNA outside the chromosomes, exists as critical oncogene driver in approximately 20% of all tumors. Massive ecDNA amplification and its asymmetric segregation during mitotic drive high level oncogene amplification and contribute to tumor heterogeneity. Gastric cancer exhibits a high frequency of ecDNA occurrence. <i>KRAS</i>, a key oncogene in multiple cancers, is frequently amplified in gastric cancer; however, its functional implications via ecDNA remain largely understudied. In this study, we performed whole-genome sequencing and single-cell RNA sequencing on a gastric cancer sample to identify genomic amplification and transcription driven by ecDNA. We identified <i>KRAS</i>-ecDNA in gastric cancer, which exhibited significantly elevated KRAS expression and pronounced transcriptional heterogeneity. Functionally, ecDNA_High cells showed enhanced ribosome biogenesis, upregulated DNA repair pathways, differential activation of transcription factors,and reduced MHC-II signaling, indicating potential immune evasion. Drug response predictions suggested that <i>KRAS</i>-ecDNA_High cells are sensitive to MAPK inhibitors and upstream receptor inhibitors, despite showing broad resistance to conventional chemotherapies. Our study uncovers the critical role of <i>KRAS</i>-ecDNA in gastric cancer. These findings provide a rationale for targeting ecDNA-driven oncogenic programs and offer targeted strategies to combat ecDNA-mediated oncogenic evolution.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

KRAS-extrachromosomal DNA drives intratumoral heterogeneity in gastric cancer

  • 期刊论文

  • 发表日期：

    2026年3月5日

查看全文
  • Rong Guan,
  • Chenxi Li,
  • Xinchun Dai,
  • Yanyan Wang,
  • Yiyuan Zhang,
  • Xiao Liang,
  • Shan Yu,
  • Zhizhou Li,
  • Kexian Dong,
  • Mengdi Cai,
  • Jie Wu,
  • Xueyuan Jia,
  • Hao Wang,
  • Dapeng Hao,
  • Songbin Fu,
  • Wenjing Sun

摘要

Extrachromosomal DNA (ecDNA), autonomously replicating circular DNA outside the chromosomes, exists as critical oncogene driver in approximately 20% of all tumors. Massive ecDNA amplification and its asymmetric segregation during mitotic drive high level oncogene amplification and contribute to tumor heterogeneity. Gastric cancer exhibits a high frequency of ecDNA occurrence. KRAS, a key oncogene in multiple cancers, is frequently amplified in gastric cancer; however, its functional implications via ecDNA remain largely understudied. In this study, we performed whole-genome sequencing and single-cell RNA sequencing on a gastric cancer sample to identify genomic amplification and transcription driven by ecDNA. We identified KRAS-ecDNA in gastric cancer, which exhibited significantly elevated KRAS expression and pronounced transcriptional heterogeneity. Functionally, ecDNA_High cells showed enhanced ribosome biogenesis, upregulated DNA repair pathways, differential activation of transcription factors,and reduced MHC-II signaling, indicating potential immune evasion. Drug response predictions suggested that KRAS-ecDNA_High cells are sensitive to MAPK inhibitors and upstream receptor inhibitors, despite showing broad resistance to conventional chemotherapies. Our study uncovers the critical role of KRAS-ecDNA in gastric cancer. These findings provide a rationale for targeting ecDNA-driven oncogenic programs and offer targeted strategies to combat ecDNA-mediated oncogenic evolution.